363 related articles for article (PubMed ID: 8658808)
1. Living related donor kidney transplantation in patients with a positive flow cytometry crossmatch.
Hong JH; Sadeghian M; Sumrani N; Distant DA; Sommer BG; Norin AJ
Transplant Proc; 1996 Jun; 28(3):1614-5. PubMed ID: 8658808
[No Abstract] [Full Text] [Related]
2. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Kitabayashi K; Munn SR; Sterioff S
Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
[No Abstract] [Full Text] [Related]
3. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
[No Abstract] [Full Text] [Related]
4. Impact of HLA matching, type of crossmatch, and immunosuppressive therapy on primary pediatric cadaver renal allograft survival.
Kerman RH; Sullivan EK; Tejani A
Transplant Proc; 1995 Feb; 27(1):656-7. PubMed ID: 7879133
[No Abstract] [Full Text] [Related]
5. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
6. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.
Abramowicz D; Norman DJ; Goldman M; De Pauw L; Kinnaert P; Kahana L; Thistlethwaite JR; Shield CF; Monaco AP; Vanherweghem JL
Transplant Proc; 1995 Feb; 27(1):852-3. PubMed ID: 7879204
[No Abstract] [Full Text] [Related]
7. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
[No Abstract] [Full Text] [Related]
8. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
[No Abstract] [Full Text] [Related]
9. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
Chen M; Wade J; Levy GA; Greig PD
Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
[No Abstract] [Full Text] [Related]
10. Kidney transplantation in pediatric population.
Mota C; Henriques C; Sarmento M; Pereira E; Xavier E; Pereira M
Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872
[No Abstract] [Full Text] [Related]
11. Strategy for improving retransplantation in the CyA era.
Dickerman R; Langley J; Brinker K; Trevino G; Melton L; Vergne-Marini P; Wilson PK
Transplant Proc; 1993 Feb; 25(1 Pt 1):257-8. PubMed ID: 8438292
[No Abstract] [Full Text] [Related]
12. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
Hariharan S; Alexander JW; Schroeder TJ; First MR
Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of donor sensitization in kidney transplant recipients by flow cytometric crossmatch.
Cinti P; Bachetoni A; Baiano V; Pretagostini R; Poli L; Berloco P; Renna Molajoni E; Cortesini R
Transplant Proc; 1993 Dec; 25(6):3265-6. PubMed ID: 8266536
[No Abstract] [Full Text] [Related]
14. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
[No Abstract] [Full Text] [Related]
15. Impact of early acute rejection on outcome of HLA-mismatched living related donor kidney transplants.
Sumrani N; Hong JH; Georgi B; Maursky V; Hassoun A; Markell MS; Distant DA; Sommer BG
Transplant Proc; 1996 Jun; 28(3):1451-2. PubMed ID: 8658736
[No Abstract] [Full Text] [Related]
16. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric crossmatching and outcome one year after renal transplantation.
Talbot D; Shenton BK; Givan AL; Cavanagh G; Proud G; Taylor RM
Transpl Int; 1992; 5 Suppl 1():S604-5. PubMed ID: 14621887
[TBL] [Abstract][Full Text] [Related]
18. Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation.
Abouna GM; Kumar MS; Stephan R; Prior JE; Lyons P; Bulova SI; al-Abdullah IH
Transplant Proc; 1993 Jun; 25(3):2241-2. PubMed ID: 8516886
[No Abstract] [Full Text] [Related]
19. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
[No Abstract] [Full Text] [Related]
20. Kidney transplantation in Cyprus.
Kyriakides GK; Hadjigavriel M; Nicolaou P; Nicolaides A; Kyriakides M
Transplant Proc; 1993 Apr; 25(2):2129-30. PubMed ID: 8470291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
